FOCAL POINTS (Courageous Discourse)

FOCAL POINTS (Courageous Discourse)

Share this post

FOCAL POINTS (Courageous Discourse)
FOCAL POINTS (Courageous Discourse)
Spirulina Supplementation for Hospitalized COVID-19 Patients

Spirulina Supplementation for Hospitalized COVID-19 Patients

Safe, Natural, Positive Results

Peter A. McCullough, MD, MPH's avatar
Peter A. McCullough, MD, MPH
Apr 23, 2024
∙ Paid
186

Share this post

FOCAL POINTS (Courageous Discourse)
FOCAL POINTS (Courageous Discourse)
Spirulina Supplementation for Hospitalized COVID-19 Patients
29
20
Share
Upgrade to paid to play voiceover

By Peter A. McCullough, MD, MPH

As we look back on the COVID-19 pandemic response debacle, a black spot is the lack of innovation or improved hospital care over time.

Aghasadeghi et al published a small randomized trial of oral supplementation with spirulina.

“Spirulina (arthrospira platensis), a filamentous, gram-negative cyanobacterium, is a blue-green microalga that is a non-nitrogen-fixing photoautotroph (19). Spirulina platensis is rich in protein (over 70%), vitamins, and minerals such as vitamin D, B12, provitamin A (beta carotene), and iron. It also contains phenolic acids, tocopherols, g-linolenic acid, and is particularly high in phycocyanobilin (PCB). PCB, a blue pigment protein, is part of the light-harvesting phycobiliprotein family and has anti-inflammatory, anti-cancer, and antioxidant properties. Spirulina platensis, which does not contain cellulose, is easily digestible (20–22). Previous studies have confirmed the anti-inflammatory properties of Spirulina platensis, demonstrating its ability to prevent and reduce inflammation by inhibiting histamine release from mast cells (20, 23, 24).”

To summarize, spirulina is a blue-green algae product. According to the National Institutes of Health (NIH), people have used doses of up to 19 g per day for a maximum of 2 months and up to 10 g per day for a maximum of 6 months. People should not exceed the dose stated on the product label—most products list a serving as 1 gram. Aghasadeghi described favorable directional changes in inflammatory markers and reductions in hard clinical outcomes with 15.2 g/day of spirulina supplementation in hospitalized COVID-19 patients.

Keep reading with a 7-day free trial

Subscribe to FOCAL POINTS (Courageous Discourse) to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Peter McCullough MD MPH
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share